Users Discontinuing Weight-Loss Jabs Regain Weight Four Times Faster Compared to Dieters

New research reveals that people who come off popular weight-loss injections like semaglutide or tirzepatide can put back on lost weight far faster than those who halt traditional diet and exercise plans.

Research printed in a prominent medical journal points out that while obese people often shed a large proportion of their total mass while on the medication, the weight is regained at an estimated rate of 0.8 kg per month upon discontinuation.

"Users using these medications should be cognizant of the danger of rapid weight regain when the treatment is stopped," stated researcher Dr. Susan Jebb.

This pace of recovery suggests a reversion to starting mass in about 18 months.

Analyzing Treatments

The study, which examined 37 of trials involving over 9,000 of patients, contrasted the outcomes of the injectable medications with older methods.

The team emphasize that people who shed pounds through diet and exercise generally experience a slower creep back—approximately 100 grams monthly—after stopping.

Understanding the Fast Rebound

Experts propose the mode of action of the jabs explains the accelerated weight return.

These medications copy a body's own chemical called glucagon-like peptide-1, which helps regulate appetite.

"Sustained high doses of GLP-1 concentrations several times higher than the body's typical production might result in the body to generate a reduced amount of its own natural hormone, and could reduce responsiveness to its actions," noted Dr. Adam Collins, a nutrition expert.

"Discontinuation of this medication results in hunger is uncontrolled, making binge eating a significant risk."

An Ongoing Disease?

Health authorities advise the jabs for people with weight-linked health risks, accompanied by prescribed lifestyle changes.

Many experts argue that, considering the significant potential of relapse, the treatment is often life-long.

This opinion is supported by drug manufacturers, who state that the findings "underscore the persistent nature of obesity," similar to managing diseases like high blood pressure.

User Accounts

People who have come off the medication explain a powerful resurgence of appetite.

"It felt as if a trigger activating and I was suddenly ravenous," recalled an individual.

The struggle is compounded if users have not established lasting dietary or behavioural modifications during treatment.

Widespread Use

Recent estimates suggest that millions of people in the UK have tried weight-loss jabs in the last 12 months, with desire being substantial.

• Use is higher among females compared to men.
• The 40s and 50s age group shows the greatest usage rates.
• A large proportion obtain the medications through private prescriptions rather than public health services.

Ultimately, researchers caution that while the jabs are effective tools for weight loss, they are not a magic cure and maintained weight loss hinges on integrated lifestyle management.